Cargando…
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
Molecular farming of pharmaceuticals in plants has the potential to provide almost unlimited amounts of recombinant proteins for use in disease diagnosis, prevention or treatment. Tobacco has been and will continue to be a major crop for molecular farming and offers several practical advantages over...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132750/ https://www.ncbi.nlm.nih.gov/pubmed/19961918 http://dx.doi.org/10.1016/j.biotechadv.2009.11.008 |
_version_ | 1783517499122253824 |
---|---|
author | Tremblay, Reynald Wang, David Jevnikar, Anthony M. Ma, Shengwu |
author_facet | Tremblay, Reynald Wang, David Jevnikar, Anthony M. Ma, Shengwu |
author_sort | Tremblay, Reynald |
collection | PubMed |
description | Molecular farming of pharmaceuticals in plants has the potential to provide almost unlimited amounts of recombinant proteins for use in disease diagnosis, prevention or treatment. Tobacco has been and will continue to be a major crop for molecular farming and offers several practical advantages over other crops. It produces significant leaf biomass, has high soluble protein content and is a non-food crop, minimizing the risk of food-chain contamination. This, combined with its flexibility and highly-efficient genetic transformation/regeneration, has made tobacco particularly well suited for plant-based production of biopharmaceutical products. The goal of this review is to provide an update on the use of tobacco for molecular farming of biopharmaceuticals as well the technologies developed to enhance protein production/purification/efficacy. We show that tobacco is a robust biological reactor with a multitude of applications and may hold the key to success in plant molecular farming. |
format | Online Article Text |
id | pubmed-7132750 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71327502020-04-08 Tobacco, a highly efficient green bioreactor for production of therapeutic proteins Tremblay, Reynald Wang, David Jevnikar, Anthony M. Ma, Shengwu Biotechnol Adv Article Molecular farming of pharmaceuticals in plants has the potential to provide almost unlimited amounts of recombinant proteins for use in disease diagnosis, prevention or treatment. Tobacco has been and will continue to be a major crop for molecular farming and offers several practical advantages over other crops. It produces significant leaf biomass, has high soluble protein content and is a non-food crop, minimizing the risk of food-chain contamination. This, combined with its flexibility and highly-efficient genetic transformation/regeneration, has made tobacco particularly well suited for plant-based production of biopharmaceutical products. The goal of this review is to provide an update on the use of tobacco for molecular farming of biopharmaceuticals as well the technologies developed to enhance protein production/purification/efficacy. We show that tobacco is a robust biological reactor with a multitude of applications and may hold the key to success in plant molecular farming. Elsevier Inc. 2010 2009-12-02 /pmc/articles/PMC7132750/ /pubmed/19961918 http://dx.doi.org/10.1016/j.biotechadv.2009.11.008 Text en Copyright © 2009 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Tremblay, Reynald Wang, David Jevnikar, Anthony M. Ma, Shengwu Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title_full | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title_fullStr | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title_full_unstemmed | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title_short | Tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
title_sort | tobacco, a highly efficient green bioreactor for production of therapeutic proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132750/ https://www.ncbi.nlm.nih.gov/pubmed/19961918 http://dx.doi.org/10.1016/j.biotechadv.2009.11.008 |
work_keys_str_mv | AT tremblayreynald tobaccoahighlyefficientgreenbioreactorforproductionoftherapeuticproteins AT wangdavid tobaccoahighlyefficientgreenbioreactorforproductionoftherapeuticproteins AT jevnikaranthonym tobaccoahighlyefficientgreenbioreactorforproductionoftherapeuticproteins AT mashengwu tobaccoahighlyefficientgreenbioreactorforproductionoftherapeuticproteins |